Users paying out of pocket spend about $203 a month, and 17% have taken on debt to stay on the drugs, per the Harris Poll survey of over 1,900 adults.
Recap by typeshit. Full story at Insurance Business.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
She covers birth control, thyroid and blood pressure drugs, including why tirzepatide and Foundayo users may need backup contraception after dose increases.
The newly published trial tested Lilly's retatrutide in adults with obesity who don't have diabetes. Dr O'Connor calls it another big step for next generation obesity drugs.
Loading…